MRM Health | WebDisclosure

Basculer en Français

9543	Companies
187932	Keywords
119871	Articles
100408	Press releases

Home
Companies
MRM Health

BRIEF

published on 12/17/2025 at 07:05, 2 hours 55 minutes ago

MRM Health Joins Forces with Oncode and Netherlands Cancer Institute

Cancer Immunotherapy Microbiome Therapies MRM Health Oncode Institute Netherlands Cancer Institute
BRIEF

published on 12/17/2025 at 07:05, 2 hours 55 minutes ago

MRM Health s'associe à Oncode et à l'Institut néerlandais du cancer

MRM Santé Thérapies Du Microbiome Immunothérapie Du Cancer Institut Oncode Institut Néerlandais Du Cancer
PRESS RELEASE

published on 12/17/2025 at 07:00, 3 hours ago

MRM Health Enters Strategic Collaboration with Oncode Institute and the Netherlands Cancer Institute to Accelerate Program on Microbiome-Based Therapies that Enhance Cancer Immunotherapy
MRM Health collaborates with Oncode Institute & Netherlands Cancer Institute to develop microbiome-based therapies enhancing cancer immunotherapy. Utilizing CORAL(R) platform for immune-oncology innovation

Cancer Immunotherapy Microbiome-based Therapies MRM Health Oncode Institute Netherlands Cancer Institute

Accesswire

Published on 12/17/2025 at 09:05, 55 minutes ago

Over 40% of Adults Struggle to Swallow Pills - BioNxt Targets a Global Adherence Problem with Rapid-Dissolving Thin-Film “Melt-in-Your-Mouth” Therapies
Published on 12/17/2025 at 08:00, 2 hours ago

Pulsar Helium Awards Security Based Compensation
Published on 12/16/2025 at 23:20, 10 hours 40 minutes ago

Tactical Resources Announces Shareholder Approval of Arrangement With Plum Acquisition Corp. III
Published on 12/16/2025 at 23:20, 10 hours 40 minutes ago

GMV Minerals Announces Upsize of Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/16/2025 at 23:07, 10 hours 53 minutes ago

Linear Minerals Corp Closes First Tranche of Private Placement Financing

View all ACCESSWIRE

EQS Group

Published on 12/17/2025 at 09:30, 30 minutes ago

Topadur Appoints Matthias Schäfer as Chief Executive Officer to Lead Next Phase of Company Growth
Published on 12/17/2025 at 09:30, 30 minutes ago

Designated Person Notification
Published on 12/17/2025 at 09:30, 30 minutes ago

Designated Person Notification
Published on 12/17/2025 at 09:21, 38 minutes ago

Heidelberg Pharma: Letter from the CEO
Published on 12/17/2025 at 09:05, 54 minutes ago

Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology

Les Echos

Published on 12/16/2025 at 21:45, 12 hours 14 minutes ago

Mise à disposition du rapport financier annuel
Published on 12/16/2025 at 20:10, 13 hours 49 minutes ago

donation of shares of Seval, member of the Feuillet family concert
Published on 12/16/2025 at 20:10, 13 hours 49 minutes ago

Donation de titres de la société Seval, membre du concert familial Feuillet
Published on 12/16/2025 at 18:53, 15 hours 6 minutes ago

Number of shares and voting rights - November 2025 (In French only)
Published on 12/16/2025 at 18:53, 15 hours 6 minutes ago

Nombre total d'actions et droits de vote - novembre 2025

View all LES ECHOS COMFI WIRE